Human C5a and C5a analogs as probes of the neutrophil C5a receptor

Becker, 1974, The ability of chemotactic factors to induce lysosomal enzyme release. I. The characteristics of the release, the importance of surfaces and the relation of enzyme release to chemotactic responsiveness, J. Immun., 112, 2047, 10.4049/jimmunol.112.6.2047

Beebe, 1978, The C5 chemotactic fragment isolated from activated human serum, J. Immun., 120, 1764, 10.4049/jimmunol.120.5.1764.b

Bokisch, 1969, Isolation of a fragment (C3a) of the third component of human complement containing anaphylatoxin and chemotactic activity and description of an anaphylatoxin inactivator of human serum, J. exp. Med., 129, 1109, 10.1084/jem.129.5.1109

Bokisch, 1970, Anaphylatoxin inactivator of human plasma: its isolation and characterization as a carboxypeptidase, J. clin. invest., 49, 2427, 10.1172/JCI106462

Boyüm, 1968, Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g, Scand. J. clin. Lab. Invest,, 21, 77

Brittinger, 1968, Studies on lysosomes. XI. Characterization of a hydrolase-rich fraction from human lymphocytes, J. Cell Biol., 37, 394, 10.1083/jcb.37.2.394

Chenoweth, 1978, Initial characterization of the human polymorphonuclear leukocyte (PMN) C5a receptor, J. Immun., 120, 1768, 10.4049/jimmunol.120.5.1768.c

Chenoweth, 1978, Demonstration of a specific C5a receptor on intact human polymorphonuclear leukocytes, 75, 3943

Chenoweth, 1979, Human C5a-related synthetic peptides as neutrophil chemotactic factors, Biochem. biophys. Res. Commun., 86, 227, 10.1016/0006-291X(79)90856-8

Chenoweth, 1979, A modified method for chemotaxis under agarose, J. immun. Meth., 25, 337, 10.1016/0022-1759(79)90026-7

David, 1974, Protein iodination with solid state lactoperoxidase, Biochemistry, 13, 1014, 10.1021/bi00702a028

Fernandez, 1976, Partial characterization of human C5a anaphylatoxin. I. Chemical description of the carbohydrate and polypeptide portions of human C5a, J. Immun., 117, 1688, 10.4049/jimmunol.117.5_Part_1.1688

Fernandez, 1978, Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin, J. biol. Chem., 253, 6955, 10.1016/S0021-9258(17)38013-4

Fernandez, 1978, Chemotactic response to human C3a and C5a anaphylatoxins. 1. Evaluation of C3a and C5a leukotaxis in vitro and under simulated in vivo conditions, J. Immun., 120, 109, 10.4049/jimmunol.120.1.109

Finney, 1964, Probit Analysis, 236

Goetzl, 1976, Structural determinants of the eosinophil chemotactic activity of the acidic tetrapeptides of eosinophil chemotactic factor of anaphylaxis, J. exp. Med., 144, 1424, 10.1084/jem.144.6.1424

Goldstein, 1973, Lysosomal enzyme release from human leukocytes: mediation by the alternate pathway of complement activation, J. Immun., 111, 33, 10.4049/jimmunol.111.1.33

Goldstein, 1973, Mechanisms of lysosomal enzyme release from human leukocytes: microtubule assembly and membrane fusion induced by a component of complement, 70, 2916

Goldstein, 1974, Generation of C5-derived lysosomal enzyme-releasing activity (C5a) by lysates of leukocyte lysosomes, J. Immun., 113, 1583, 10.4049/jimmunol.113.5.1583

Henry, 1960, Revised spectrophotometric methods for the determination of glutamic-oxalacetic transaminase glutamic-pyruvic transaminase, and lactic acid dehydrogenase, Am. J. clin. Path., 34, 381, 10.1093/ajcp/34.4_ts.381

Henson, 1978, Intracellular control of human neutrophil secretion. I. C5a-induced stimulus-specific desensitization and the effects of cytochalasin B, J. Immun., 121, 851, 10.4049/jimmunol.121.3.851

Hofmann, 1963, The importance of artificial peptides in elucidation of physiological events, Harvey Lect., 59, 89

Hughli, 1977, Synthetic peptides with the biological activities and specificity of human C3a anaphylatoxin, 74, 1826

Hugli, 1975, Purification and partial characterization of human and porcine C3a anaphylatoxin, J. biol. Chem., 250, 1472, 10.1016/S0021-9258(19)41837-1

Lowry, 1951, Protein measurement with the Folin phenol reagent, J. biol. Chem., 193, 265, 10.1016/S0021-9258(19)52451-6

Minta, 1977, Cleavage of human C5 by trypsin: characterization of the digestion products by gel electrophoresis, J. Immun., 119, 1597, 10.4049/jimmunol.119.5.1597

Natali, 1979, Antibody-coated protein A-bearing Staphylococcus aureus: a versatile and stable immune reagent, J. immun. Meth., 25, 255, 10.1016/0022-1759(79)90113-3

Perez, 1979, Mechanism of action of a specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with lupus erythematosus, Clin. Res., 27, 333A

Rudinger, 1971, The design of peptide hormone analogs, Vol. 2, 319

Shin, 1968, Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement, Science, 162, 361, 10.1126/science.162.3851.361

Showell, 1976, The structure-activity relations of synthetic peptides as chemotactic factors and inducers of lysosomal enzyme secretion for neutrophils, J. exp. Med., 143, 1154, 10.1084/jem.143.5.1154

Snyderman, 1968, Interactions of the complement system with endotoxic lipopolysaccharide. Generation of a factor chemotactic for polymorphonuclear leukocyles, J. exp. Med., 128, 259, 10.1084/jem.128.2.259

Snyderman, 1970, Polymorphonuelear leukocyte chemotactic activity in rabbit serum and guinea pig serum treated with immune complexes. Evidence for C5a as the major chemotactic factor, Infect. Immun., 1, 521, 10.1128/IAI.1.6.521-525.1970

Snyderman, 1977, Biological aspects of leukocyte chemotaxis, 159

Spackman, 1958, Automatic recording apparatus for use in the chromatography of amino acids, Analyt. Chem., 30, 1190, 10.1021/ac60139a006

Spackman, 1963, Accelerated system for the automatic analysis of amino acids, 22, 244

Tack, 1976, Third component of human complement: purification from plasma and physiochemical characterization, Biochemistry, 15, 4513, 10.1021/bi00665a028

Vallota, 1973, Formation of C3a and C5a anaphylatoxins in whole human serum after inhibition of the anaphylatoxin inactivator, J. exp. Med., 137, 1109, 10.1084/jem.137.5.1109

Ward, 1965, The role of serum complement in chemotaxis of PMNs, J. exp. Med., 122, 327, 10.1084/jem.122.2.327

Ward, 1966, Further studies on the chemotactic factor of complement and its formation in vivo, Immunology, 11, 141

Ward, 1967, A plasmin-split fragment of C'3 as a new chemotactic factor, J. exp. Med., 126, 189, 10.1084/jem.126.2.189

Ward, 1969, A neutrophil chemotactic factor from human C'5, J. Immun., 102, 93, 10.4049/jimmunol.102.1.93

Ward, 1970, C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils, J. Immun., 104, 535, 10.4049/jimmunol.104.3.535

Zettner, 1973, Principles of competitive binding assays (saturation analyses). I. Equilibrium techniques, Clin. Chem., 19, 699, 10.1093/clinchem/19.7.699

Zigmond, 1977, Chemotaxis by polymorphonuclear leukocytes, J. Cell Biol., 77, 269, 10.1083/jcb.77.2.269